Federal Register of Legislation - Australian Government

Primary content

PB 47 of 2019 Other as made
This instrument amends Schedule 1 of the National Health (Pharmaceutical benefits – early supply) Instrument 2015 (PB 120 of 2015) to add, delete and alter listed pharmaceutical items and associated periods and circumstances.
Administered by: Health
Registered 28 Jun 2019
Tabling HistoryDate
Tabled HR02-Jul-2019
Tabled Senate02-Jul-2019
Date of repeal 17 Sep 2019
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

PB 47 of 2019

 

National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 6)

 

National Health Act 1953

___________________________________________________________________________

 

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

 

Dated     27 June 2019

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health


 

___________________________________________________________________________

1          Name of Instrument

(1)          This Instrument is the National Health (Pharmaceutical Benefits – early supply) Amendment Instrument 2019 (No. 6).

(2)          This Instrument may also be cited as PB 47 of 2019.

2          Commencement

This Instrument commences on 1 July 2019.

3          Amendment of National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015)

Schedule 1 amends the National Health (Pharmaceutical Benefits—early supply) Instrument 2015 (PB 120 of 2015).

 


Schedule 1       Amendments

[1]        Schedule 1, entry for Esomeprazole

substitute:

Esomeprazole

Capsule (enteric) 20 mg (as magnesium) 

20

30

5

 

Capsule (enteric) 40 mg (as magnesium)

20

30

5

 

Tablet (enteric coated) 20 mg (as magnesium trihydrate)

20

30

5

 

Tablet (enteric coated) 40 mg (as magnesium trihydrate)

20

30

5

[2]        Schedule 1, omit entry for Glatiramer

[3]        Schedule 1, omit entry for Isotretinoin

[4]        Schedule 1, entry for Lansoprazole

substitute:

Lansoprazole

Capsule 15 mg 

20

30

5

 

Capsule 30 mg

20

28

5

 

Tablet 15 mg (orally disintegrating)

20

28

5

 

Tablet 30 mg (orally disintegrating)

20

28

5

[5]        Schedule 1, entry for Omeprazole

substitute:

Omeprazole

Capsule 20 mg 

20

30

5

 

Tablet 10 mg (as magnesium)

20

30

5

 

Tablet 20 mg

20

30

5

 

Tablet 20 mg (as magnesium)

20

30

5

 

[6]        Schedule 1, entry for Pantoprazole

substitute:

Pantoprazole

Sachet containing granules 40 mg (as sodium sesquihydrate) 

20

30

5

 

Tablet (enteric coated) 20 mg (as sodium sesquihydrate)

20

30

5

 

Tablet (enteric coated) 40 mg (as sodium sesquihydrate)

20

30

5

[7]        Schedule 1, entry for Rabeprazole

substitute:

Rabeprazole

Tablet containing rabeprazole sodium 10 mg (enteric coated) 

20

28

5

 

Tablet containing rabeprazole sodium 20 mg (enteric coated)

20

30

5

[8]        Schedule 1, omit entry for Rosiglitazone with metformin